Editas Medicine, Inc. Common Stock (NASDAQ: EDIT) last traded at $3.11, up 5.78% on the session. The quote above updates while this page is open; the figures below are drawn from Editas Medicine, Inc. Common Stock’s own filings and are restated only when a new one is published.
Editas Medicine, Inc. Common Stock trades on NASDAQ under the ticker EDIT. Its market capitalisation is $477.63 million.
Valuation measures for Editas Medicine, Inc. Common Stock, derived from the latest quote and its most recent SEC filing.
| Market cap | $477.63M |
|---|---|
| Enterprise value | $427.90M |
| Price / sales | 10.16 |
| Price / book | 4.54 |
| Beta | 2.13 |
Trailing-twelve-month figures tagged in Editas Medicine, Inc. Common Stock's XBRL filings with the SEC.
| Revenue (TTM) | $47.01M |
|---|---|
| Net income (TTM) | -$73.95M |
| Operating margin | -161.39% |
| Return on equity | -70.24% |
| Cash | $181.81M |
Range and volume for EDIT over the past 52 weeks.
| 52-week high | $4.54 |
|---|---|
| 52-week low | $1.66 |
| Volume | 2.07M |
| Average volume | 2.79M |
| Previous close | $2.94 |
A dash means FurlPay does not have that figure, not that it is zero. Nothing on this page is investment advice or a recommendation to buy or sell any security. Figures are provided for information only and may be delayed or restated.